{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:28:44Z","timestamp":1761197324325},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,6,10]],"date-time":"2015-06-10T00:00:00Z","timestamp":1433894400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin J Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s40880-015-0021-y","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T08:24:56Z","timestamp":1434011096000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Qualitative visual trichotomous assessment improves the value of fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography in predicting the prognosis of diffuse large B-cell lymphoma"],"prefix":"10.1186","volume":"34","author":[{"given":"Xu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Ying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong-Jun","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,10]]},"reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1200\/JCO.2005.09.131","volume":"23","author":"P Feugier","year":"2005","unstructured":"Feugier P, Van Hoof A, Sebban C, Solal-Celigny P, Bouabdallah R, Ferm\u00e9 C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the groupe d\u2019Etude des lymphomes de l\u2019Adulte. J Clin Oncol. 2005;23:4117-26.","journal-title":"J Clin Oncol"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.ijrobp.2008.02.068","volume":"72","author":"A Ballonoff","year":"2008","unstructured":"Ballonoff A, Rusthoven KE, Schwer A, McCammon R, Kavanagh B, Bassetti M, et al. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis. Int J Radiat Oncol Biol Phys. 2008;72:1465-71.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1023\/A:1008308129857","volume":"10","author":"B Coiffier","year":"1999","unstructured":"Coiffier B. How to interpret the radiological abnormalities that persist after treatment in non-Hodgkin\u2019s lymphoma patients? Ann Oncol. 1999;10:1141-3.","journal-title":"Ann Oncol"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5732\/cjc.014.10124","volume":"34","author":"X Zhang","year":"2015","unstructured":"Zhang X, Fan W, Xia Z, Hu Y, Lin X, Zhang Y, et al. Use of subsequent PET\/CT in diffuse large B-cell lymphoma patients in complete remission following primary therapy. Chin J Cancer. 2015;34:70-8.","journal-title":"Chin J Cancer"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma. J Clin Oncol. 2007;25:571-8.","journal-title":"J Clin Oncol"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579-86.","journal-title":"J Clin Oncol"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00259-003-1120-6","volume":"30","author":"K Spaepen","year":"2003","unstructured":"Spaepen K, Stroobants S, Dupont P, Bormans G, Balzarini J, Verhoef G, et al. [(18)F]-FDG PET monitoring of tumour response to chemotherapy: does [(18)F]-FDG uptake correlate with the viable tumour cell fraction? Eur J Nucl Med Mol Imaging. 2003;30:682-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00277-010-1135-6","volume":"90","author":"C Yoo","year":"2011","unstructured":"Yoo C, Lee DH, Kim JE, Jo J, Yoon DH, Sohn BS, et al. Limited role of interim PET\/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP. Ann Hematol. 2011;90:797-802.","journal-title":"Ann Hematol"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1182\/blood-2011-06-359943","volume":"119","author":"P Pregno","year":"2012","unstructured":"Pregno P, Chiappella A, Bell\u00f2 M, Botto B, Ferrero S, Franceschetti S, et al. Interim 18-FDG-PET\/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP. Blood. 2012;119:2066-73.","journal-title":"Blood"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Haioun C, Gallamini A, Haioun C. Report on the first international workshop on interim-PET scan in lymphoma. Leuk Lymphoma. 2009;50:1257-60.","journal-title":"Leuk Lymphoma"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med. 1993;329:987-94.","journal-title":"N Engl J Med"},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2967\/jnumed.112.110890","volume":"54","author":"A Biggi","year":"2013","unstructured":"Biggi A, Gallamini A, Chauvie S, Hutchings M, Kostakoglu L, Gregianin M, et al. International validation study for interim PET in ABVD-treated, advanced-stage Hodgkin lymphoma: interpretation criteria and concordance rate among reviewers. J Nucl Med. 2013;54:683-90.","journal-title":"J Nucl Med"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1182\/blood-2005-01-0272","volume":"106","author":"C Haioun","year":"2005","unstructured":"Haioun C, Itti E, Rahmouni A, Brice P, Rain JD, Belhadj K, et al. [18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome. Blood. 2005;106:1376-81.","journal-title":"Blood."},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0212-6982(09)70696-2","volume":"28","author":"C Ramos-Font","year":"2009","unstructured":"Ramos-Font C, Rebollo Aguirre AC, Villegas Portero R, Romero Tabares A, Gallego Peinado M, Llamas Elvira JM. 18\u00a0F-fluorodeoxyglucose positron emission tomography in the evaluation of therapy response assessment in lymphomas. Systematic literature review and meta-analysis. Rev Esp Med Nucl. 2009;28:48-55 [in Spanish].","journal-title":"Rev Esp Med Nucl"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s00277-007-0413-4","volume":"87","author":"D Focosi","year":"2008","unstructured":"Focosi D, Caracciolo F, Galimberti S, Papineschi F, Petrini M. False-positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma. Ann Hematol. 2008;87:343-4.","journal-title":"Ann Hematol"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/01.rlu.0000222952.30225.66","volume":"31","author":"CD Ford","year":"2006","unstructured":"Ford CD, Gabor F, Morgan R, Dabbas B. False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma. Clin Nucl Med. 2006;31:391-3.","journal-title":"Clin Nucl Med"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1093\/annonc\/mdi272","volume":"16","author":"NG Mikhaeel","year":"2005","unstructured":"Mikhaeel NG, Hutchings M, Fields PA, O\u2019Doherty MJ, Timothy AR. FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma. Ann Oncol. 2005;16:1514-23.","journal-title":"Ann Oncol"},{"key":"21_CR18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1200\/JCO.2001.19.2.414","volume":"19","author":"K Spaepen","year":"2001","unstructured":"Spaepen K, Stroobants S, Dupont P, Van Steenweghen S, Thomas J, Vandenberghe P, et al. Prognostic value of positron emission tomography (PET) with fluorine-18fluorodeoxyglucose ([18\u00a0F]FDG) after first line chemotherapy in non-Hodgkin\u2019s lymphoma: is [18\u00a0F]FDG-PET a valid alternative to conventional diagnostic method? J Clin Oncol. 2001;19:414-9.","journal-title":"J Clin Oncol"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/1535370213498985","volume":"238","author":"SA Maxwell","year":"2013","unstructured":"Maxwell SA, Mousavi-Fard S. Non-Hodgkin\u2019s B-cell lymphoma: advances in molecular strategies targeting drug resistance. Exp Biol Med (Maywood). 2013;238:971-90.","journal-title":"Exp Biol Med (Maywood)"},{"key":"21_CR20","first-page":"563216","volume":"2011","author":"JJ Castillo","year":"2010","unstructured":"Castillo JJ, Rizack T, Treaba D. Immunophenotypical switch versus tumor heterogeneity in a patient with HIV-associated diffuse large B-cell lymphoma. Patholog Res Int. 2010;2011:563216.","journal-title":"Patholog Res Int"}],"container-title":["Chinese Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-015-0021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40880-015-0021-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-015-0021-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40880-015-0021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T14:53:55Z","timestamp":1630594435000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancercommun.biomedcentral.com\/articles\/10.1186\/s40880-015-0021-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,10]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1186\/s40880-015-0021-y","relation":{},"ISSN":["1944-446X"],"issn-type":[{"value":"1944-446X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,10]]},"assertion":[{"value":"24 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"20"}}